Spontaneous orthotopic liver allograft acceptance associated with microchimerism in mice induces tolerance to subsequent skin or heart transplants from the donor but not third-party animals. Despite in vivo hyporesponsiveneu, in vitro MLC and CTL assays showed continuing anti donor reactivity. Cells isolated from recipients' spleens and grafted livers, when tested in MLC and CTL assays, were antidonor reactive out to 3 months to the same degree as splenocytes obtained from either naive or presensitized (with skin or heart) mice. Nevertheless, passive transfer of splenocytes or liver lymphocytes from liver tolerant mice, but not naive or sensitized donor strain mice, were able to prolong skin graft survival significantly in naive irradiated recipients. By using a strain combination in which the donor but not the recipient expressed the stimulatory endogenous super-Ag (MIs,), it was possible to determine whether super-Ag-reactive T cells bearing VIJ5 and VlJl1 were deleted or anergic. Phenotypic analysis of cells isolated from recipients' spleens and grafted livers (up to 90 days after transplant). when compared with naive animals. showed no significant difference in VIJ5 and VfJll TCR expression. Additionally, when these isolated spleen cells were tested for antibody-mediated stimulation. both anti-VlJ6 and VfJll TCR mAb led to marked proliferation of cells obtained from naive and liver-transplanted recipients. but as expected, proliferation was very low in cells from naive donors. These results suggest that liver transplantation induces donorspecific tolerance in vivo, which may not be reflected in in vitro proliferative and cytotoxicity assays (split tolerance). Furthermore. this tolerance does not seem to be induced by clonal deletion or anergy of minorlymphocyte-stimwating-antigen-reactive T cells in the recipients.
Spontaneous orthotopic liver allograft acceptance associated with microchimerism in mice induces tolerance to subsequent skin or heart transplants from the donor but not third-party animals. Despite in vivo hyporesponsiveneu, in vitro MLC and CTL assays showed continuing anti donor reactivity. Cells isolated from recipients' spleens and grafted livers, when tested in MLC and CTL assays, were antidonor reactive out to 3 months to the same degree as splenocytes obtained from either naive or presensitized (with skin or heart) mice. Nevertheless, passive transfer of splenocytes or liver lymphocytes from liver tolerant mice, but not naive or sensitized donor strain mice, were able to prolong skin graft survival significantly in naive irradiated recipients. By using a strain combination in which the donor but not the recipient expressed the stimulatory endogenous super-Ag (MIs,), it was possible to determine whether super-Ag-reactive T cells bearing VIJ5 and VlJl1 were deleted or anergic. Phenotypic analysis of cells isolated from recipients' spleens and grafted livers (up to 90 days after transplant). when compared with naive animals. showed no significant difference in VIJ5 and VfJll TCR expression. Additionally, when these isolated spleen cells were tested for antibody-mediated stimulation. both anti-VlJ6 and VfJll TCR mAb led to marked proliferation of cells obtained from naive and liver-transplanted recipients. but as expected, proliferation was very low in cells from naive donors. These results suggest that liver transplantation induces donorspecific tolerance in vivo, which may not be reflected in in vitro proliferative and cytotoxicity assays (split tolerance). Furthermore. this tolerance does not seem to be induced by clonal deletion or anergy of minorlymphocyte-stimwating-antigen-reactive T cells in the recipients.
OLT in mice across major and minor histocompatibility barriers results in a high incidence of spontaneous graft acceptance without immunosuppression (1) . While some strain combinations (B10 ~ C3H) fare better (mean survival> 100 days) than others (BALB/c -+ C3H; mean survival> 47 days), the underlying mechanism(s) for this extemporaneous liver graft acceptance in an unmodified recipient is not clear. However, this property is not unique to the liver, only much stronger, since kidneys (2, 3) and hearts (4) in some strain combinations in mice can also lead to induction of donor-specific tolerance. The present study was designed to analyze the functional status of lymphocytes isolated from various lymphoid and nonlymphoid organs of liver graft recipients, and to investigate the role of minor lymphocyte-stimulating (MIs)· super-Ag and V(3 usage in the induction of donorspecific tolerance after OLT. For the latter study, an I-ElMls(' positive liver was grafted into an I-ElMls('negative recipient, which provided us with a direct approach to examine V(3 usage in the periphery.
MATERIALS AND METHODS
Animals. Inbred male mice of the C57BUlO (BlO), BlO.BR, B10.02. C3HJHeJ. and BALB/c strains were obtained from Jackson Laboratory, Bar Harbor, ME. Mice were maintained in pathogen-free facilities, provided with Purina rodent chow and tap water ad libitum, and used at 10-12 weeks of age.
Medium. Oulbecco's modified Eagle's medium ([DMEM] GlBCO. Grand Island. NY) supplemented with 2 mM L-glutamine (GlBCO>, 0.55 mM L-arginine (GIBCO>. 0.3 mM L-asparagine (GlBCO>. 13.6 ~ folic aCid (GIBCO>. 100 Ulml penicillin lGIBCO), 1001lg/mlstrep· tomycin (GIBC01. 1 mM sodium pyruvate (Sigma Chemical Co., St. Louis. MOl. 10 mM HEPES (Sigma), 5x 10-6 ~ 2-ME (GlBCOl. and 0.75% mouse serum were used (complete OMEM) for all cell cultures except CytotoXICity and T cell activation assays, where instead of mouse serum. 10% decomplemented FCS (GIBCOl was used 'MLC-OMEMl.
Sur!?lcal techniques. OLT was perfonned as described preVIously ,5l. Abdominal heterotopIc heart transplantatIOn was perfonned as descnbed preVIously by Ono and Lindsey \ Ii I. Transplanted hearts were mOnitored dally by direct palpation. and rejection was defined as tenninatlOn of palpable cardiac contractllitv. A full-thickness skin graft from the donor tail was placed on the dorsal side of the reCipient's trunk according to a prevlOusly descnbed technique (71. The 'AbbreVlatlons: DMEM. Dulbecco's modified Eagle's medium: ~lls. minor lvmphocyte-stimulatlng antigen. graft was secured by silk sutures, and protected by dressing for 7 to 8 days. The rejection process was monitored by daily inspection until the skin was completely destroyed. All procedures were performed under methoxyflurane anesthesia.
Histology. Animals were killed on days 2, 7, 14.28, and 84 after transplantation. Tissues were harvested and fixed in neutral buffered formalin, embedded in paraffin. sectioned. and stained with hematoxylin and eosin.
Preparation of cell suspensions. Aseptically harvested spleens and lymph nodes were gently teased with 25-gauge needles in culture medium. and subsequently filtered through a nylon mesh.
Erythrocytes were lysed by treatment with 5 ml of red cell lysing buffer (Sigma) for 5 min, and washed twice with complete DMEM.
Free lymphomyeloid cells from the liver were prepared as described previously (8) . Briefly, the portal vein was exposed and cannulated with a 21-gauge needle and the inferior vena cava was transected proximal to the renal veins. The liver was then perfused with 40 ml of warm Hank's solution. excised, and transferred to sterile culture medium. Perfused livers were disrupted on a 50-mesh stainless steel sieve with a sterile 200m! syringe pestle, and the resulting cell suspension was filtered through a nylon mesh. Further purification was achieved by centrifugation on a continuous 35% Percoll (Pharmacia Diagnostics, Piscataway, NJ) gradient. Cells in the pellet were recovered, treated for 5 min with RBC lysis buffer, and. after 2 washes. resuspended in appropriate volume of complete DMEM.
MLC. All mixed cell culture assays were performed in triplicate in round-bottomed microtiter plates (Corning, Corning, NY) using equal numbers (2X10 6 Cytotoxlcitv assays. Effector cells from spleens were prepared by incubating equal numbers (4X lOti cellslwelll of responders and 'Y-ir· radiated (2000 cGy) stimulators (syngeneic. donor. and third party) for 4 to 5 days in a 12·well tissue culture plate (Coming). On the contrary. freshly isolated free lymphomyeloid cells from the grafted livers were used as effectors. Target cells were prepared by incubating 4 x lOb spleen cells for 48 hr in MLC-DMEM containing Con A I Sigma) at 51lg/ml. The target cells were then labeled with Na~51Cr04 I NEN) and washed 3 times to remove excess :;ICr. and 4 x 10" cellsl well were placed in V-bottomed 96-well tissue culture plates (Corn-109). Serial3-fold dilutions of effector cells were added at a maximum E:T rabo of 100: 1 in a total volume of 200 Ill/well. and the plates were incubated for 4 to 5 hr at 37°C in 10% CO,. At the end of this lOcubation. plates were centrifuged at 500x,l;' f~r 10 min. and 100 III tlf supernatant from each well were removed for counting. Spontaneous "ICr release from target cells was determined bv incubating urgets With medium alone. The percentage of speCific 5lCr release was calculated according to the formula: " specllic 51Cr release Irpm expenmental -rpm spontaneous I
• 100 Icpm maXlmum -cpm spontaneous I
The n"sults are expressed as mean cpm = 1 SD of r;. speCific 5lCr n'iease 10 tnplicate cultures.
Flnw cvtnmetrlc analvsls. Cells isolated from spleens and grafted livers were phenotvped by smgle-color Immunotluorescence labeling with the following FITC-conjugated rat anti-mouse mAb (Pharmingen, San Diego, CAl: anti-Thy-1 (lgG2c:' pan T cell antigen), anti-CD4 OgG2b' L3T4. Th cells). anti-CD8 <IgG2a' Ly-2, cytotoxic/suppressor T cells), and anti-CD45R <IgG2a' B220, pre-B and B lymphocytes).
FITC-conjugated. isotype-matched irrelevant mAb were used as appropriate negative controls. For surface marker analysis, 5X 10 6 cells were incubated with 100 III (1:100 dilution) of appropriate mAb for 60 min at 4°C. The cells were washed twice, resuspended in PBS containing 1% paraformaldehyde, and analyzed using a FACScan flow cytometer (Becton-Dickinson, Mountain View, CAl.
Cells isolated from spleens, lymph nodes. thymus, and grafted livers were also analyzed for relative frequency of various subsets of TCR. by double immunofluorescent staining with the following mAb (Pharmingen): phycoerythrin-conjugated anti-Thy-l (rat IgG2c:) and anti-CD3-E (hamster IgG), FITC-conjugated or biotinylated anti-VI33 TCR (hamster IgG), anti-VI35.l, 5.2 TCR (mouse IgGI)' anti-VI38.1,8.2 TCR (mouse IgG2a)' and anti-VI311 TCR (rat IgG~. Cells (5X 10 6 cellsltube) were first incubated for 60 min at 4°C with 100 ~ of phycoerythrin-conjugated anti-Thy-1 mAb (1:100 dilution). The cells were then washed twice and 100 p.l of FITC-conjugated or bietinylated anti-CD3 or anti-V/3 TCR mAb were added at 1:100 dilution. After 60 min of incubation at 4°C, the cells were washed and only those cells that were stained with biotinylated mAb were further incubated for 30 min at 4°C with 100 ~ of streptavidin-conjugated FITC (1:100 dilution, Jackson Immunoresearch Laboratory, West Drove. PAl. All cells were washed. resuspended in 1% paraformaldehyde, and finally analyzed on a FACScan flow cytometer (Becton-Dickinson). Fluorochrome-conjugated, isotype-matched irrelevant mAb were used as an appropriate negative control.
Adoptive transfer assays. All adoptive transfer assays were performed in the strain combination BlO -> C3H. Cells were isolated from spleens of naive animals (C3H), from C3R recipients of B10 liver or skin (4 weeks after transplant), and from transplanted BlO -+ C3R livers (4 weeks after transplant). They were finally resuspended at 2X 10 7 cellslml in Hank's solution and 500 p.l (Le., 10 7 cells/animal) were infused through the penile vein into sublethally irradiated (650 cGy) naive C3H recipients (syngeneic). These cell transplant recipients were simultaneously challenged with a fullthickness skin graft from a B10 donor.
TeR cross·linking assay. T cell proliferation was induced by cross-linking TCR with mAb directed against T cell surface antigens: CD3. VJ33. V135, V!38. and VI311 TCR. The assay was performed as described prevlOusly (35) . Briefly. 100 III of relevant antibody solution (10 Ilg/mll were incubated overnight at 37°C in 96-well U-bottomed microtiter plates (Coming). At the end of this incubation period. plates were washed with sterile Hank's solution. and 2x10 6 spleen cells were then added to each well in a final volume of 200 III of MLC-DMEM. The cells were cultured for 3 to 5 days at 37°C in 10% CO 2 , with [JHlthymidine (1llCilweli) added for the last 16-18 hr of culture. Plates were harvested onto glass filter mats and the lJHlthymldine mcorporation was determined by liquid scintillation spectrophotometry. Negative controls were cells cultured with MLC-DMEM alone. Positive controls were cells cultured with either Con A (Table lL Normal BID and C3H livers had approximately equal numbers of Band T cells. whereas atter transplantation. the maJonty of isolated cells from allografted but not syngrafted livers were T lymphocytes ( Table 1) . Of the T cell subsets, CD8+ cells far outnumbered CD4 + cells in the allografted livers ( Table 1) . On the contrary, the phenotype of splenocytes isolated from liver, heart, or skin recipients was similar to naive controls (data not shown).
Proliferative responses of cells isolated from spleens and grafted livers. AB early as 8 days after liver transplantation, the recipients' (C3R) spleen celis showed alloreactivity toward "'(-irradiated donor (ElO) and third-party (BALB/c) splenocytes (Fig. IB) , while sustaining nonresponsiveness to autologous lymphocytes (Fig. IB) 14,30, and 90) after liver transplantation (Fig. lD) . A similar lymphoproliferative response was also observed in spleen cells isolated from skin and heart transplant recipients (BlO -+ C3H, 90 days after transplant) who had rejected their grafts within 14 days (Fig. 2) 
NaiveC3H
OLTx HTx (Fig. 3B and 3D) . Lysis of third-party (BALB/c) targets was as effective as donor, whereas killing of syngeneic targets was low, ranging between 2% and 6% (Fig. 3, B and D) . Similar observations were also made for spleen cells isolated after skin or heart transplantation (data not shown). Freshly isolated lymphocytes from spleens of liver graft recipients and grafted livers were also tested for their cytotoxic capacity. Cells isolated from grafted livers (8-90 days after transplant), but not spleens, showed high alloreactive cytolysis of both donor and third-party targets, with minimal lysis of syngeneic targets (Table 2 ). transplant) delayed skin graft rejection far beyond nonnal controls (Table 3) .
Effect of liver transplantation on Vi3 TCR usage in the periphery.
To investigate what role clonal deletion of superAg-reactive T cells might play in inducing tolerance after liver transplantation. lymphocytes from spleens. lymph nodes. and thymus of naive and liver-grafted animals were examined for Vi3 TCR usage. Peripheral T cells of B10.BR (MlsrPositive) donors do not express V{35 (0.94%) and V{311 (1.0%) segments of TCR, whereas T cells of B10 (MIs,-negative) recipients expressed relatively high levels ofVj35 (6.4%) and V{311 (5.5%) TCR (Fig. 4) . However, both animals express comparable levels ofV{33 (3.25:t3%) and V{38 (16:t1%) TCR. which serve as positive controls. While examining spleen cells from liver transplant recipients (2-90 days after transplant), we found that donor super-Ag-reactive T cells expressing V{35 and V{311 TCR were not deleted (Fig. 4) . Cells isolated from recipients'lymph nodes, thymus. and grafted liver also expressed normal levels ofV{35 and V{311 TCR (data not shown). Similar results were also obtained in rejecting B10.BR --+ B10 skin graft recipients (6-15 days after transplant). Expression ofV{33 and V{38 TCR in transplanted animals was comparable to naive controls (Fig. 4) .
Antibody-mediated proliferation of peripheral T cells after liver transplantation. If purging of donor super-Ag-reactive T cells is not the basis for tolerance induction, could it be that these cells are rendered functionally inert (clonal "anergy" or "silencing") by donor cells migrating out of transplanted livers? To test this hypothesis. spleen cells isolated from naive and transplanted recipients were stimulated with a panel of anti-V{3 TCR mAb. Cells isolated from naive BlO (recipient) showed a proliferative response when cultured with anti-Vi35
----,---~. and anti-VI311 TCR mAb, whereas B10.BR (donor) did not respond beyond background controls. Both B10 and B10.BR responded equally well to anti-CD3-E (data not shown), antiVt33, and anti-Vf38 TCR mAb (Fig. 5) . Cells isolated from spleens of liver graft recipients (2-90 days after transplant) responded in consonance with naive B10 by proliferating vigorously to anti-CD3-E, anti-Vt35, and anti-VI311 TCR mAb stimulation (Fig. 5) , suggesting that donor super-Ag-reactive T cells in the recipient are functionally active. DISCUSSION We have demonstrated that liver transplantation in mice across major and minor histocompatibility barriers resulted in spontaneous graft acceptance and induction of donor-specific tolerance (1 ) . Systemic tolerance to the donor was illustrated by the observation that other donor organs, such as heart and skin, were protected from rejection by the grafted liver, whereas third-party organs were rejected within the normal time course (1) . Moreover, hepatic tolerogenicity was so robust that an ongoing skin graft rejection was reversed by subsequent liver transplant, thus reverting a state of sensitization to one of tolerance (1) . Similar observations have also been made by Kamada et al., who showed that in the DA -to PVG rat strain combination, liver was only rejected if the recipient was presensitized against donor antigens (9) (10) (11) (12) . Despite the liver's potentially strong tolerogenic capacity, this attribute is not uniquely ascribed to them, since kidneys (2, 3) and hearts (4) in some strain combinations in mice can also lead to spontaneous graft acceptance and induction of donor-specific tolerance.
In addition to specific systemic hyporesponsiveness to the donor, these liver graft recipients also exhibited the establishment of microchimerism (1 ), which we have reported pre---E c. 
: viously is an inevitable outcome of all successful whole organ transplantation (13) (14) (15) (16) (17) (18) . However, this in vivo nonreactivity to the donor was not maintained in vitro, since cells isolated from the spleens of long-term liver graft recipients (up to 90 days after transplantation) when tested in an MLC, responded vigorously to irradiated donor as well as to thirdparty stimulators, whereas response to syngeneic stimulators was very low. These cells also exhibited elevated levels of cytotoxicity both toward the donor and third party lymphocytes and cultured bile duct cells. This cytotoxic activity was evident at an E:T ratio as low as 3:1. The autologous cell lysis was very low « 6%), suggesting that this killing was not due to lymphokine-activated killer cells, but rather due to the generation of specific cytotoxic cells early after liver transplantation. This dichotomy between in vivo hyporesponsiveness and in vitro alloreactivity has been referred to as "split tolerance" (19, 20) . These findings are in agreement with those in rats (9, 10, 12) and in humans (21) , further supplementing our own assertion that in vitro observations are not always a true prediction of the in vivo immune status of the recipient.
Several attempts have been made to associate the phenotypic profile of graft-infiltrating cells with immunological responses to the allografts. Of particular interest are the phenotypes of cells infiltrating the graft and their in vivo and in vitro immunological status. A relative increase in CD8+ T cells with the reversal of the CD4 to CD8 ratio has been demonstrated in the cells infiltrating acutely rejecting rat cardiac allografts (22) and human (23) and rat renal (24) allografts. In our study, we also found a similar reversal of the CD4 to CD8 ratio 1 week after allogeneic but not syngeneic liver transplantation, which was sustained throughout the observation period (12 weeks after transplant). Furthermore, despite significant and continuously persistent donor and third-party MLC and CTL alloreactivity, these liver graft-infiltrating cells appeared to be innocuous in vivo, as there was little morphological evidence of hepatocellular necrosis.
In adoptive transfer assays in rats, Kamada et a1. demonstrated that transfusion of thoracic duct lymphocytes from liver-grafted animals into irradiated syngeneic recipients resulted in prolongation of skin grafts of the donor, but not third-party, strains (9) (10) (11) 25) . Similar observations were also made in our experiments in mice. where we found that donor but not third-party skin graft survival was significantly prolonged in naive syngeneic sublethally irradiated mice that were reconstituted with cells isolated from either spleens or livers of long-term liver allograft recipients. On the contrary, donor skin graft survival was not prolonged in irradiated syngeneic animals that were reconstituted with splenocytes from skin-sensitized mice.
Clonal deletion of immature T cells in the thymus bearing Mis-reactive TCR subsets is an established mechanism for the induction of self-tolerance (26) (27) (28) (29) . The relationship among clonal deletion. chimerism. and donor-specific tolerance induction has also been reported by Streilein and coworkers in an J-E-disparate neonatal transplantation model (30) (31) (32) . Furthermore. clonal deletion or anergy of mature T cells in the periphery has also been proposed as an alternative mechanism for the induction of tolerance to self or alloantigens (33) (34) (35) (36) (37) (39) , who showed that the induction of specific tolerance in nude mice that were reconstituted with donor-strain thymic epithelium at birth was not due to clonal deletion or anergy of super-Ag-reactive T cells in the recipients. In summary, our studies demonstrate that spleen and liver graft-infiltrating cells in recipients of liver allografts, though hyporesponsive in vivo, exhibit a strong donor and thirdparty alloreactivity in vitro (split tolerance). The complete absence of autologous/syngeneic reactivity suggests that this cytolytic response is not due to engendering of lymphokineactivated killer cells, but probably due to the generation of specific cytotoxic T cells after liver grafting. The significantly prolonged acceptance of donor, but not third-party, skin grafts by irradiated animals that were reconstituted with spleen or liver graft-infiltrating cells obtained from long-term liver allograft recipients is an affirmation that these cells are capable of transferring tolerance to naive syngeneic animals. Furthermore, clonal deletion or anergy of MIs-reactive T cells is not the basis for tolerance induction after liver transplantation in mice. Finally, liver-induced tolerance to the donor IS probably not mediated by any suppressor factors in the recipient's serum (manuscript in preparation). A possible explanation of this paradox might be inherent in the donor bone-marrow-derived cells, which after whole organ transplantation are known to migrate from the allograft into the recipient, leading to the establishment of chimerism, which is thought to be the first step toward subsequent induction of donor-specific tolerance (], 18). 
